# Orion Corporation, Orion Pharma – FDA Inspection, Sep 6, 2019

Source: https://www.keypedia.com/records/fda_inspections/orion-corporation-orion-pharma/7dabdec6-b523-4c4f-a96a-08558f1f8d4e
Source feed: FDA_Inspections

> FDA inspection 1106590 of Orion Corporation, Orion Pharma, September 06, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1106590
- Company Name: Orion Corporation, Orion Pharma
- Inspection Date: 2019-09-06
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1309538 - 2024-04-25
- FDA Inspection 1201298 - 2022-03-10
- FDA Inspection 992916 - 2016-11-03
- [FDA Inspection 889323 - 2014-06-19](https://www.keypedia.com/records/fda_inspections/orion-corporation-orion-pharma/d32fa6e1-8861-4b46-a8a1-096325b9f6f5)
- FDA Inspection 836582 - 2013-05-24

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/nicholas-l-hunt/2f10c080-c02e-4cc3-a8a0-0675b9c4cc6d)

Company: https://www.keypedia.com/companies/orion-corporation-orion-pharma/afdfe2db-9213-4d8d-84c3-4627195bb4c7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c